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Urinary tract infections continue to be among the most common extraintestinal diseases. Cystitis in women
is by far the most common urinary tract infection; pyelonephritis in both sexes and prostatitis in men are more
severe but less frequent complaints. Escherichia coli is by far the most common cause of urinary tract infection.
It is believed that uropathogenic E. coli is adept at colonizing the urinary tract via the production of specific
virulence factors. Recently, a novel virulence determinant, Vat, was described for the prototypical uropatho-
genic E. coli strain CFT073. Vat is a member of the SPATE (serine protease autotransporters of the Enter-
obacteriaceae) subfamily of the autotransporters. Previously, SPATEs have been described for all pathovars of
E. coli, but until recently their presence had been noticeably absent in nonpathogenic E. coli. In this report we
describe the prevalence and phylogenetic distribution of the SPATEs among uropathogenic E. coli and the
ECOR collection, demonstrating an association between the presence of the SPATEs, including Vat, and
uropathogenic E. coli phylogroups. In addition, we describe the distribution of SPATEs among nonpathogenic
E. coli.
Escherichia coli is the predominant cause of urinary tract
infections (UTIs), accounting for 50% of all nosocomial uri-
nary tract infections and 90% of infections among ambulatory
patients (6). Among UTIs, cystitis in women is by far the most
common, with the more severe complaints pyelonephritis and
prostatitis being less frequent (34). The production of specific
virulence factors is thought to be necessary for uropathogenic
E. coli (UPEC) to colonize the urinary tract (6, 8). These
factors include adhesins, capsule, aerobactin, toxins, and pro-
teases, which may aid attachment to host mucosal tissues, allow
evasion of immune defenses, and promote invasion of the
normally sterile urinary tract and tissues (1, 8, 24, 32). UPEC
strains have a greater prevalence of virulence factors than
commensal E. coli, with virulence determinants being more
prevalent among strains causing invasive rather than noninva-
sive disease (13, 22, 32). However, half of all UPEC isolates
possess none, or only one, of the virulence factors character-
ized thus far, and hence other as yet uncharacterized bacterial
factors may be important in the pathogenesis of UTI (22).
The genome sequence of the UPEC strain CFT073 has been
completed, and this has propagated the identification of fur-
ther potential virulence genes (35). Autotransporters are one
category of secreted proteins implicated in the virulence of
UPEC (17, 18). Members of the serine protease autotransport-
ers of the Enterobacteriaceae (SPATE) family are proteins
from E. coli and Shigella spp. which, like the immunoglobulin
A1 (IgA1) proteases and Hap autotransporters of Neisseria
and Haemophilus spp., possess a consensus serine protease
motif (19). Since the description of the first SPATE (30), a
number of investigators have described SPATE proteins in the
different pathotypes of E. coli and in Shigella (2, 9, 12, 16, 27).
SPATE proteins possess several common features: (i) all pos-
sess an unusual extended signal sequence, (ii) the serine pro-
tease active site is reminiscent of a chymotrypsin clan protease,
(iii) unlike the IgA1 proteases, none of the SPATE family has
been shown to cleave IgA1, (iv) the serine protease motif of
SPATE proteins does not have a role in cleavage of the pas-
senger domain from the -domain, (v) the point of cleavage of
passenger domains from the -domains is identical, (vi) each
SPATE member is among the predominant secreted proteins
of their respective pathogens, and (vii) SPATEs are associated
with pathogenic strains (18). While the full contribution of
these proteins to pathogenesis remains elusive, and no univer-
sal contribution has been suggested, specific phenotypes have
been reported for various members of the SPATE family (7,
17).
Several reports have identified multiple autotransporters in
single strains of E. coli (27, 31). Hence, we used in silico
analyses of the E. coli CFT073 genome sequence to identify
uncharacterized autotransporter proteins that might be asso-
ciated with uropathogenesis. We recently documented the
presence of 10 members of the autotransporter family in
UPEC CFT073, including three SPATEs: Sat, PicU, and Vat
(27). Sat is a toxin which has vacuolating cytotoxic activity
against bladder and kidney cells (12, 14). PicU, a homologue of
the Pic autotransporter identified in Shigella flexneri and en-
teroaggregative E. coli (EAEC), demonstrates mucinase activ-
ity (27). Vat, the vacuolating autotransporter toxin recently
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described for avian pathogenic E. coli (APEC), causes vacuol-
ization of chicken embryo fibroblasts in vitro and was shown to
be vital for virulence of APEC strain Ec222 (28). The prolific
existence of members of the SPATE subfamily of autotrans-
porters in the prototypical UPEC strain CFT073 suggests that
the ability of E. coli to cause UTI may be associated with the
presence of SPATE proteins. Hence, we sought to screen a
collection of UPEC isolates that caused invasive or noninva-
sive UTIs and the ECOR collection of E. coli strains in order
to determine the association of SPATE autotransporters, and
in particular Vat, with clinical disease.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The prototypical UPEC strain
CFT073 was isolated from the blood of a woman with pyelonephritis (23).
Ninety-four E. coli strains isolated from clinical cases of cystitis or pyelonephritis
in women, or prostatitis in men, were obtained from J. Ruiz (Barcelona, Spain).
These strains were previously characterized for the prevalence of nine uropatho-
genic virulence factors (32). The ECOR collection, a phylogenetically character-
ized collection of E. coli strains, which consists of 10 human UTI isolates, 1
asymptomatic bacteriuria human isolate, and 61 fecal isolates from healthy
human and animal hosts representing all of the phylogenetic groups, was de-
scribed previously (25). A collection of 43 E. coli blood culture isolates were
obtained from the clinical laboratories at the Queen Elizabeth Hospital, Bir-
mingham, United Kingdom, in 2003. All strains were grown overnight at 37°C on
Luria-Bertani (LB) agar plates to check purity. Overnight LB broth cultures were
then used for DNA preparations using the DNeasy tissue kit (QIAGEN, Craw-
ley, United Kingdom) following the manufacturer’s instructions.
Phylogenetic grouping of the blood culture isolates was performed using the
method described by Clermont et al. (4). Briefly, DNA from each strain was
amplified with primers for chuA and positive samples were subsequently ampli-
fied with primers corresponding to yjaA, whereas negative samples were ampli-
fied with primers corresponding to tspE4C2; samples positive for yjaA represent
the B2 cluster, samples negative for yjaA represent the D group, samples positive
for tspE4C2 represent the B1 cluster, and samples negative for tspE4C2 represent
the A group.
Bioinformatic analysis of the CFT073 genome. To characterize the genomic
context of vat, the E. coli CFT073 genome sequence was compared to other E.
coli and Shigella sp. strains using coliBASE, an online database for E. coli
comparative genomics (3). This contains all the complete E. coli, Shigella, and
Salmonella genome sequences, together with preliminary data from a number of
sequencing projects currently in progress at The Wellcome Trust Sanger Insti-
tute. The database contains precalculated genome alignments performed using
MUMmer and PROmer and provides user-friendly tools to display pairwise
comparisons between equivalent regions of different strains and to highlight
chromosomal insertions, deletions, and rearrangements.
PCR detection of SPATEs. PCR primers for vat (5-GAACACAGTTCATCT
GATCTCC-3 and 5-GAATATATCAAATTGGTCCCCC-3) were designed
against open reading frame (ORF) c0393 (accession no. AAN78874) of the
uropathogenic E. coli strain CFT073. The resultant amplicon was 419 bp in
length and corresponds to nucleotide positions 375551 to 375133 of the CFT073
genome sequence. PCR primers to detect genes encoding SPATE proteins (5-
YAAYYTNAAYAARMGNATGGG-3 and 5-RTTRTAYYTMCCRAANGC
NGA-3) were designed against conserved regions of the -domain as deter-
mined through multiple alignments; the resultant amplicon was 793 bp in length.
Genomic DNA preparations were tested for vat and for SPATE-encoding genes
in 50-l PCR mixtures containing 15 pmol of each of the forward and reverse
primers, 10 nmol of each deoxynucleoside triphosphate, 1 U of Taq DNA poly-
merase (Invitrogen, Paisley, United Kingdom), and 2 mM MgCl2 in 1 PCR
buffer (Invitrogen). The PCR conditions were as follows: initial incubation at
94°C for 2 min, followed by 30 cycles of denaturation at 94°C for 15 s, annealing
at 55°C for 30 s, and extension at 72°C for 45 s. A final extension step of 72°C for
10 min was also included. Products were analyzed by electrophoresis through
0.8% (wt/vol) agarose gels with ethidium bromide as a visualization agent. The
sizes of amplicons were determined by comparison to the 1-kb plus DNA ladder
(Invitrogen). E. coli K12 (MG1655) and UPEC CFT073 were used as negative
and positive controls, respectively. DNA preparations that were initially found to
be negative for vat or SPATE-encoding genes were retested using different DNA
concentrations and annealing at 50°C in order to allow for small variations in
primer-site sequence between strains. The prevalence data was analyzed online
(http://www.matforsk.no/ola/fisher.htm) using a two-tailed Fisher’s exact test to
test for statistical significance.
RESULTS
Genomic context of vat. Previous in silico analyses of UPEC
CFT073 identified an ORF encoding the 148-kDa Vat protein
(27). BLAST analyses revealed that Vat was homologous to a
number of SPATE proteins from several different pathogenic
strains of E. coli and was virtually identical at the nucleotide
level (99.9%) to the Vat identified in an avian pathogenic
strain of E. coli Ec222 (28). In UPEC CFT073, Vat was pre-
viously annotated as the SPATE proteins hemoglobin protease
(Hbp) and Tsh (15, 35); however, closer inspection revealed
that UPEC CFT073 Vat was in fact a separate protein and
displayed only 78% identity with these two proteins. Like the
other SPATEs, Vat possesses a consensus serine protease mo-
tif (G258DSGSP) which is characteristic of the SPATE subfam-
ily of autotransporters, the IgA1 proteases of Neisseria, and
Hap of Haemophilus. Indeed, examination of the Vat predicted
amino acid sequence revealed conserved histidine residues
(H130) and aspartic acid (D158) which, with the conserved
serine residue of the consensus region, are presumed to form
the catalytic triad of an enzyme active site reminiscent of the
SA (chymotrypsin) clan of serine proteases (10).
The vat gene is present on a 7.8-kb insertion relative to the
E. coli K12 MG1655 genome sequence (Fig. 1). The vat inser-
tion is found at positions 370301 to 378080 of the E. coli
CFT073 genome and is inserted between the genes proA and
yagU, which in E. coli K12 contains a 39.9-kb region (262172 to
302124), rich in insertion and phage-like elements and genes of
unknown function but which is not present in E. coli CFT073
(Fig. 1). Analyses of several other strains of E. coli revealed
that vat was present in the same position in UPEC strain 536,
APEC Ec222, and the neonatal meningitis E. coli strain RS218.
Interestingly, both UPEC 536 and APEC Ec222 possessed
additional DNA inserts which were not homologous. The ad-
ditional sequence in UPEC 536 encoded the S-fimbriae asso-
ciated with binding to sialic acid moieties on eukaryotic cells,
the iro locus associated with iron acquisition, and an additional
autotransporter termed Antigen 43; the additional sequence in
APEC Ec222 was homologous to insertion and phage-like el-
ements and genes of unknown function (5, 28). Examination of
this region in the diarrheagenic strains of E. coli whose ge-
nomes have been completed revealed all strains contained an
insertion between proA and yagU. Surprisingly, with the excep-
tion of the enteroaggregative E. coli strain 042 and the entero-
hemorrhagic E. coli strain EDL933, which share seven con-
served genes, the sequences in this region were dissimilar when
compared to each other and when compared to the extraintes-
tinal strains of E. coli.
Distribution of SPATEs among the ECOR collection. E. coli
is a highly clonal species represented by four major phyloge-
netic groups, i.e., A, B1, B2, and D (6, 25). To determine the
phylogenetic distribution of vat, and specifically if it was pref-
erentially associated with the extraintestinal phylogenetic
groups (B2 and D), we used PCR with primers specific for the
vat gene to survey the well-defined ECOR collection. Of the 57
non-B2 strains, 1 (ECOR23) was found to be positive for vat.
We previously demonstrated that ECOR23, an elephantine
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isolate of group A, has an uncharacteristic complement of
UPEC-related virulence genes for this phylogenetic group
(26). The prevalence of vat in the non-B2 group (1.8%) was
significantly lower (P  2  1010) than for the B2 group
(86.7%; Fig. 2).
To determine whether SPATE proteins in general were
preferentially associated with the extraintestinal phylogenetic
groups, we used PCR to determine the distribution of SPATE-
encoding genes among the ECOR collection. Using a set of
primers corresponding to conserved regions of the -domain,
no product could be detected in reactions with E. coli K-12
genomic DNA, but as expected, the presence of an appropri-
ately sized PCR product could be detected in amplifications
with E. coli CFT073 DNA. Similarly, products corresponding
to genes encoding SPATE proteins were detected in the B2
and D groups and a subgroup of the A phylogenetic branches
(Fig. 2). Nevertheless, the distribution of SPATE proteins was
significantly higher (P  0.00001) in the B2 group (93.3%)
than in the non-B2 clusters (29.8%; Fig. 2).
Prevalence of SPATEs among extraintestinal clinical iso-
lates of E. coli. As the SPATEs were associated with extra-
intestinal phylotypes, it was of interest to determine whether
the SPATEs were associated with a particular UTI; thus, the
presence of genes encoding SPATEs were detected by PCR in
a collection of pathogenic E. coli strains isolated from cystitis,
pyelonephritis, and prostatitis (Fig. 3). No statistically signifi-
cant difference was observed between any of the groups of
isolates. Similarly, PCR was used to test the collections of
pathogenic E. coli isolates for the presence of vat. The distri-
bution of vat was similar in cystitis (57.9%) and pyelonephritis
(59.3%) isolates. While the prevalence of vat was higher in
prostatitis isolates (72.4%), the increase was not significant
when compared to cystitis or pyelonephritis strains. Further-
more, the distribution of the SPATEs and vat occurs at a
similar rate in all the clinical groups when compared to the B2
phylogenetic cluster.
To investigate whether the SPATEs or vat was associated
with E. coli strains which possess the capacity to invade the
FIG. 1. Genetic organization of the proA-yagU region of E. coli. The gene organization and content of the proA-yagU region of genome-
sequenced E. coli strains is depicted. The vat gene is found in the same position and orientation in all the extraintestinal pathogens but is absent
from the intestinal pathogenic isolates. With the exception of several genes conserved among EAEC 042, EHEC EDL933, and E. coli K12, the
genetic content of each island is remarkably distinct, indicating that this region is a hotspot for recombination. Loci shared between pathogenicity
islands are highlighted in the same color. Loci previously implicated in pathogenesis are shaded and labeled. UPEC, uropathogenic E. coli; NMEC,
neonatal meningitis E. coli; EPEC, enteropathogenic E. coli; EHEC, enterohaemorrhagic E. coli; EAEC, enteroaggregative E. coli.
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bloodstream, their distribution in 43 strains of E. coli isolated
from patients with septicemia was examined by PCR (Fig. 3).
The distribution of the SPATE proteins within the septicemia
isolates occurred at a frequency similar to the other clinical
isolates and the ECOR B2 phylogenetic cluster. Surprisingly,
while vat demonstrated a prevalence in the septicemia isolates
statistically similar to the cystitis and pyelonephritis isolates, it
exhibited a lower prevalence than the B2 group and prostatitis
isolates (P 0.0025 and P 0.008, respectively). To determine
whether the distribution was biased by a population of septi-
cemia isolates which were not representative of the B2 phylo-
genetic cluster, the phylogenetic grouping was determined for
each septicemia isolate using the method described by Cler-
mont et al. (4). This revealed that the population was com-
posed of 26 B2, 4 B1, 4 D, and 4 A isolates. Comparison of the
B2 septicemia isolates with the B2 ECOR isolates revealed no
statistically significant difference in the prevalence of vat or
SPATEs. Comparison of the distribution of the vat locus
among the non-B2 ECOR collection and the non-B2 septice-
mia isolates revealed no statistical difference in the prevalence
of the loci. In contrast, the non-B2 septicemia isolates demon-
strated a higher prevalence of SPATEs than the non-B2
ECOR collection (64.7% versus 29.8%; P  0.001).
Phylogenetic analysis of the SPATEs. Previously, Henderson
et al. (19) suggested that the SPATE family of autotransporters
could be divided into two groups: group A demonstrating cy-
topathic activity and exemplified by Pet of enteroaggregative
E. coli (EAEC) and group B exhibiting preference for extra-
cellular targets, as illustrated by Pic of EAEC and Shigella spp.
(9, 16). Recently, Dutta et al. (7) explored the phylogenetic
relationships of a subset of SPATE proteins using split decom-
position analyses of the complete passenger domains. Since
this initial study several additional members of the SPATE
subfamily have been described for E. coli and Salmonella bon-
gorii, including Vat (28), EspI (5), EatA (29), EpeA (21), EaaA
(33), EaaC (33), and Boa (accession no. AY876285; Hender-
son et al., unpublished results). Thus, we examined the rela-
tionships of the larger SPATE family and the functional activ-
ities ascribed to each member of the family. Using split
decomposition analyses, separate comparisons were made of
the functional passenger domains and of the outer membrane
transporting -domains. These analyses revealed different un-
rooted dendrograms (Fig. 4). The dendrogram generated for
the passenger domains revealed evidence of numerous recom-
bination events among the functional moieties of the SPATEs
(Fig. 4A) and much less recombination among the transporting
units (Fig. 4B). While the original bifurcating phylogenetic
pattern proposed by Henderson et al. (19) continues to be
valid for the passenger domains, Vat remains the only member
of the group B branch of the SPATEs to demonstrate cyto-
pathic activity. Interestingly, however, the same evolutionary
pattern does not hold for the -domains; EpeA and EspP have
virtually identical -domains, yet the corresponding passenger
domains reside on separate branches of the bifurcating phylo-
gram (Fig. 4). Furthermore, EaaA and EaaC, two autotrans-
porters from the nonpathogenic strain ECOR9, are the most
distantly related when compared with those isolated from
pathogenic isolates.
DISCUSSION
Recently we described the existence of several autotrans-
porters in the UPEC strain CFT073, including the SPATE
proteins Vat, Sat, and PicU (27). Further investigation re-
vealed that Vat was encoded on a 7.8-kb genomic island in-
serted at the thrW tRNA locus, between the proA and yagU
genes. Examination of all of the genome-sequenced strains of
E. coli revealed dissimilar sequences of varying sizes in this
region, suggesting that this site is a hotspot for recombination.
Interestingly, vat is present in the same orientation in the
FIG. 2. Distribution of SPATEs among the ECOR collection. Phy-
logenetic tree of the ECOR isolates showing the distribution of vat and
SPATE-encoding genes where each locus is represented by a shaded
box as indicated in the figure. The number of the ECOR isolate is
given in boldface, and each of the major phylogenetic branches is
indicated. The vat gene is preferentially associated with the B2 phylo-
genetic cluster, whereas SPATE-encoding genes show a wider distri-
bution. The figure was adapted from reference 20.
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proA-yagU region of the extraintestinal pathogens E. coli 536,
Ec222, and RS218, despite the fact that these strains possess
markedly different genetic compositions in this region. Such
conservation within a subset of pathogenic strains suggests that
Vat might be important in allowing E. coli to cause disease.
This hypothesis is supported by the fact that Vat was recently
demonstrated to be necessary for invasion of host tissues and
full virulence of the APEC strain Ec222 (28). Furthermore,
Heimer et al. (15) demonstrated by reverse transcription-PCR
that vat was expressed in mice during experimental urinary
tract infection though the contribution of Vat to infection in
this model was not reported.
In an effort to determine whether vat was associated with
extraintestinal pathotypes we examined the ECOR collection
of E. coli strains. The majority of extraintestinal pathogenic E.
coli strains, including those with the most robust virulence
factor repertoires and those most able to infect the noncom-
promised host, are found within the B2 and D phylogenetic
groups. In contrast, diarrheagenic pathotypes occur almost ex-
clusively in the A, B1, D, and ungrouped phylogenetic clusters
(6). In accordance with our initial hypothesis, vat was found to
be significantly more prevalent in the B2 cluster, suggesting an
association with extraintestinal disease. However, screening of
a collection of extraintestinal pathogenic E. coli isolates re-
vealed that vat was prevalent in a statistically similar distribu-
tion among cystitis, pyelonephritis, prostatitis, and septicemia
isolates despite the discovery of vat in several strains of E. coli
with the ability to invade the bloodstream: CFT073, RS218,
and Ec222. While these data suggest that the presence of vat
does not contribute to invasive disease, they do not rule out the
possibility that Vat contributes to initial colonization steps
which subsequently lead to UTI and septicemia. Interestingly,
while most extraintestinal E. coli clinical isolates are derived
from the B2 phylogroup, not all members of the B2 phylogroup
cause extraintestinal disease, thus vat may be represented more
frequently among pathogenic isolates than this data suggests.
Furthermore, the existence of multiple SPATEs suggests an
element of functional redundancy such that the absence of Vat
may be compensated for by the presence of other SPATEs.
Investigation of the ECOR collection revealed that SPATE
proteins were clustered in the B2 and D groups and a subgroup
of the A phylogenetic branches (Fig. 3). The absence of the
SPATEs from the majority of the B1 strains, and the remain-
der of the A subgroup, appears unusual due to the fact that at
least one SPATE, and in many cases several, have been iden-
tified in all of the diarrheagenic and extraintestinal pathovars
of E. coli (17, 18). To date no SPATE has yet been character-
ized in a nonpathogenic organism. Interestingly, many of the
strains comprising the ECOR collection have been isolated
from healthy people or animals (25), which demonstrates that
SPATE proteins are not exclusively associated with pathogens
and therefore may not play an exclusive role in virulence. The
existence of SPATEs in nonpathogenic E. coli is further sup-
ported by the recent description of the vacuolating toxin Sat in
the probiotic strain E. coli Nissle 1917 (11).
Interestingly, despite their high levels of homology, the
SPATE proteases demonstrate distinct substrate specifici-
ties (7). Previous studies suggested that the SPATE family
of autotransporters could be divided into two groups, one
demonstrating cytopathic activity, and the other exhibiting
preference for extracellular targets and this was confirmed
in this study for a larger group of SPATE proteins (7, 19).
While these investigations were unable to establish a corre-
lation between the phylogenetic groupings and biological
activity, they did reveal evidence of significant homologous
recombination among family members. Such recombination,
taken in conjunction with the presence of Boa in S. bongori,
suggests a common ancestral SPATE protein spread by hor-
izontal gene transfer and that each strain that acquired a
SPATE has adapted it to its specific niche. Thus, it is plau-
sible that some SPATEs play a role in pathogenesis whereas
others have evolved a role in conferring fitness among com-
mensal strains of E. coli. Indeed, the most distantly related
SPATEs are the EaaA and EaaC proteins of nonpathogenic
E. coli, whereas those associated with pathogenic strains are
more closely related. Furthermore, the statistically signifi-
cant association of SPATEs with septicemic isolates of the
FIG. 3. Prevalence of SPATEs in extraintestinal E. coli clinical isolates. The vat and SPATE-encoding loci were detected by PCR in clinical
isolates of E. coli. Prevalence is indicated as a percentage of the total population of strains associated with each clinical syndrome. No statistically
significant difference in the distribution of SPATEs was observed among the extraintestinal clinical isolates. The vat gene is present at a significantly
higher rate in prostatitis isolates when compared to septicemia strains; however, the prevalence of vat among the other groups is statistically similar.
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non-B2 phylogenetic groups suggests that in some circum-
stances SPATEs may contribute to pathogenicity.
In summary, we have demonstrated that vat is specifically
associated with extraintestinal phylogenetic groups of E. coli
but have not been able to demonstrate a correlation with a
specific clinical manifestation. Furthermore, we have shown
that SPATE proteins are not confined to pathogenic strains of
E. coli and thus the full contribution of SPATEs to pathogen-
esis and the ability of organisms to thrive in a particular niche
need further examination.
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